IDH1-MUTATED MALIGNANCIES
Clinical trials for IDH1-MUTATED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new IDH1-MUTATED MALIGNANCIES trials appear
Sign up with your email to follow new studies for IDH1-MUTATED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug trial targets patients with organ impairment
Disease control Recruiting nowThis study tests an oral drug called ivosidenib in 30 adults with IDH1-mutated cancers (like leukemia or solid tumors) who also have liver or kidney issues. Researchers want to see how the drug behaves in the body and if it's safe. Participants take the drug daily in 28-day cycle…
Matched conditions: IDH1-MUTATED MALIGNANCIES
Phase: PHASE1 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated Jun 16, 2026 20:49 UTC
-
New combo therapy targets tough blood cancers
Disease control Recruiting nowThis study tests a combination of drugs for people whose blood cancer (like AML or MDS) has come back or not responded to treatment. Participants must have specific gene changes (IDH1 and another signaling mutation). The goal is to see if the combination is safe and tolerable. Ab…
Matched conditions: IDH1-MUTATED MALIGNANCIES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC